![]() |
市場調査レポート
商品コード
1754163
コロストミーバッグの市場レポート:タイプ別、エンドユーザー別、地域別、2025~2033年Colostomy Bags Market Report by Type (Drainable Stoma Bags, Care Accessories), End User (Retail Pharmacies, Hospitals, Outpatient Clinics, Community Healthcare Centers, and Others), and Region 2025-2033 |
||||||
カスタマイズ可能
|
コロストミーバッグの市場レポート:タイプ別、エンドユーザー別、地域別、2025~2033年 |
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2~3営業日
|
世界のコロストミーバッグの市場規模は、2024年に12億3,560万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに14億7,090万米ドルに達し、2025~2033年の成長率(CAGR)は1.9%になると予測しています。同市場は、大腸がんや炎症性腸疾患(IBD)の有病率の増加、高齢者人口の増加、償還政策の改善によるヘルスケア支出の増加、バッグのデザインや素材の急速な進歩、オストミーケアに対する認識と受容の高まりなどを背景に、大きな成長を遂げています。
大腸がんと炎症性腸疾患の有病率の増加
大腸がんおよびクローン病や潰瘍性大腸炎などの炎症性腸疾患(IBD)の罹患率の増加は、コロストミーバッグ市場成長の重要な促進要因です。大腸がんは世界中で3番目に多いがんで、がん患者全体の約10%を占め、がんに関連した死因の第2位です。その治療にはしばしば人工肛門になる外科的介入が必要です。同様に、IBDの重症例では、腸の一部を切除して人工肛門を造設する外科手術が行われることがあります。米国では毎年7万人が新たにIBDと診断されています。また、8万人の子供たちがIBDに苦しんでいます。このような疾患の増加により、皮膚の保護とケア、そしてストーマに関連した合併症の予防の必要性がコロストミーバッグで強調されています。
高齢者人口の増加
高齢者人口への人口動態の変化は、ヘルスケアシステムに大きな影響を与えます。高齢になるにつれ、大腸がん、憩室炎、その他の加齢に伴う消化器疾患など、コロストミーバッグの使用が必要となる疾患を患う可能性が高くなります。2020年には、60歳以上の人口が5歳未満の子供を上回りました。2015~2050年の間に、世界の人口に占める60歳以上の割合は12%から22%へとほぼ倍増することが判明しています。この変化により、外科手術が必要な慢性疾患の発生率が高くなり、コロストミーバッグの使用につながっています。欧州における健康・高齢化・退職に関する調査(SHARE)の報告書によると、EU諸国平均で65歳以上の約37%が少なくとも2つの慢性疾患を抱えていると報告されています。
ヘルスケア支出の増加と償還政策の改善
医療費の増加、中間層の人口増加、高度な医療インフラの整備により、世界各国でコロストミーバッグの導入が進んでいます。例えば、インドのヘルスケアに対する公的支出は、23年度にはGDPの2.1%、22年度には2.2%に達しています。同様に欧州では、2022年の一般政府医療支出は1兆2,210億ユーロ、GDPの7.7%に達しました。このような拡大により、病院やヘルスケア施設における先進的なコロストミーバッグの利用やアクセスが容易になり、患者が高品質の製品を受けられるようになっています。さらに、患者の経済的負担を軽減する保険適用や償還制度に関する有利な政策が、必要な外科手術を選択するよう促しています。米国国勢調査局によると、2022年には、92.1%の人、すなわち米国では3億400万人が、その年のある時点で健康保険に加入していました。
The global colostomy bags market size reached USD 1,235.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,470.9 Million by 2033, exhibiting a growth rate (CAGR) of 1.9% during 2025-2033. The market is experiencing significant growth, driven by the increasing prevalence of colorectal cancer and inflammatory bowel diseases (IBD), the rising geriatric population, heightened healthcare expenditure with improved reimbursement policies, rapid advancements in bag design and materials, and the growing awareness and acceptance of ostomy care.
Increasing Prevalence of Colorectal Cancer and Inflammatory Bowel Diseases
The rising incidence of colorectal cancer and inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis is a significant driver for the colostomy bags market growth. Colorectal cancer is the third most common cancer across the globe, accounting for approximately 10% of all cancer cases, and is the second leading cause of cancer-related deaths. Its treatment often necessitates surgical interventions that result in colostomies. Similarly, severe cases of IBD can lead to surgical procedures where a portion of the intestine is removed, and a colostomy is created. As many as 70,000 new cases of IBD are diagnosed in the United States each year. The country also has 80,000 children suffering from IBD. The increased rate of these diseases has highlighted the need for colostomy bags for skin protection and care and to prevent stoma-related complications.
Growing Geriatric Population
The demographic shift toward the geriatric population has profound implications for healthcare systems. As people age, they are more likely to suffer from conditions that necessitate the use of colostomy bags, such as colorectal cancer, diverticulitis, and other age-related gastrointestinal diseases. In 2020, the number of people aged 60 years and older outnumbered children younger than 5 years. It has been found that between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. This shift has resulted in a higher incidence of chronic diseases that may require surgical interventions, leading to the use of colostomy bags. Based on a report by the Survey on Health, Ageing and Retirement in Europe (SHARE), about 37% of people aged 65 and over report having at least two chronic diseases on average across EU countries.
Rising Healthcare Expenditure and Improved Reimbursement Policies
Several countries across the globe are witnessing a hike in the adoption of colostomy bags owing to the rising expenditure on healthcare, the growing population of the middle class, and the establishment of advanced healthcare infrastructures. For instance, India's public expenditure on healthcare reached 2.1% of GDP in FY23 and 2.2% in FY22. Similarly, in Europe, the general government spending on health amounted to €1221 billion or 7.7% of GDP in 2022. This expansion is facilitating the availability and accessibility of advanced colostomy bags in hospitals and healthcare facilities to make sure that patients receive high-quality products. Additionally, favorable policies on insurance coverage and reimbursement schemes that reduce the financial burden on patients are encouraging them to opt for necessary surgical procedures. In 2022, 92.1 percent of people, or 304.0 million in the U.S., had health insurance at some point during the year, as per the U.S. Census Bureau.
Drainable stoma bags accounts for the majority of the market share
As per the colostomy bags market trends and analysis, drainable stoma bags hold the largest share. They are highly preferred due to their convenience and cost-effectiveness, particularly for patients who require frequent bag changes. Moreover, they can be emptied and reused multiple times before disposal, making them ideal for individuals with high-output stomas. Besides this, drainable stoma bags offer greater flexibility and ease of use that enhances patient comfort and reduces the overall cost of ostomy care. Additionally, the rising product demand owing to their practicality, as they significantly improve the quality of life for ostomy patients by allowing them to manage their condition more effectively and discreetly, is increasing the colostomy bags market size and share.
Retail pharmacies hold the largest share of the industry
As per the colostomy bags market forecast and research report, retail pharmacies dominated this market due to their widespread accessibility and convenience for patients seeking colostomy care products. They provide a crucial point of distribution, ensuring that patients can easily obtain necessary supplies without the delays that are associated with hospital procurement processes. Retail pharmacies also offer personalized customer service, which is essential for patients who need guidance on product selection and usage, thereby positively influencing the colostomy bags market dynamics and revenue. Additionally, they stock a diverse range of bags, including the latest innovations, ensuring that patients have access to high-quality and varied options.
North America leads the market, accounting for the largest colostomy bags market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. According to the report, North America represents the largest regional market for colostomy bags.
According to the colostomy bags market insights and outlook, North America accounted for the largest market share, attributed to several factors, including a high prevalence of colorectal cancer and inflammatory bowel diseases (IBD). Moreover, the advanced healthcare infrastructure, robust medical research, and widespread access to cutting-edge medical technologies, ensuring high-quality care and the availability of innovative colostomy products, is catalyzing the market growth. Additionally, the presence of leading manufacturers and a well-established distribution network that facilitates efficient product supply and availability, is bolstering the colostomy bags demand.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)